BioNTech’s Bold Leap: Navigating Losses to Lead the Battle Against Cancer
BioNTech's Q4 2024 earnings exceeded forecasts but marked a decline from the previous year, with earnings per share at €1.08 versus €1.90 last year. Annual results showed a net loss…